Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Two Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery Regarding Postoperative Bleeding: Total Heparin Administered Versus Residual Heparin Determined by a Pharmacokinetic Model

NCT04628884 is registered in ClinicalTrials.gov with Fundación Clínica Shaio as lead sponsor.

NCT NCT04628884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04628884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Two Strategies for Protamine Dosing After Anticoagulation in Cardiovascular Surgery Regarding Postoperative Bleeding: Total Heparin Administered Versus Residual Heparin Determined by a Pharmacokinetic Model
Lead sponsor
Fundación Clínica Shaio
Phase
Phase 4
Overall status
Unknown status
Start date
November 15, 2020
Completion date
November 22, 2021
Enrollment
136 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant antagonist toxicity